Physician profile
Kofi Vandyck
NPI 1932302684
$4,215.23
in general payments reported to CMS, 2019-2025
17 companies · $2,607 in 2025
The $2,607 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $14.81 · 2021: $234 · 2022: $115 · 2023: $527 · 2024: $564 · 2025: $2,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Travel and Lodging: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.49 |
| Travel and Lodging | $1,576.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,847.82 | 2025 | Triclip |
| Abiomed | $929.81 | 2023-2025 | Impella |
| Hemosonics LLC | $390.64 | 2021-2025 | Quantra Qplus System, Qunatra Qplus System |
| Merck Sharp & Dohme LLC | $277.52 | 2019-2024 | Bridion |
| Chiesi USA, INC. | $193.54 | 2021-2024 | Cleviprex, Kengreal |
| Livanova USA, INC. | $149.99 | 2024 | Essenz |
| Medline Industries LP | $79.97 | 2022-2024 | |
| Becton, Dickinson and Company | $64.69 | 2025 | Hemosphere |
| Masimo Corporation | $52.26 | 2021 | |
| La Jolla Pharmaceutical Company | $49.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.77 | 2023-2024 | |
| Edwards Lifesciences Corporation | $39.81 | 2019-2023 | Mitris Resilia Mitral Valve |
| Medtronic, INC. | $26.14 | 2024 | Penditure |
| Inari Medical, INC. | $19.82 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Octapharma USA, INC. | $18.62 | 2025 | Fibryga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $17.18 | 2019 | |
| Kerecis Limited | $17.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kofi Vandyck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.